Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Nemera

www.nemera.net Nemera

20 Avenue de la Gare
La Verpilliere
38292
France

+33 474 940654

Activities

Drug Delivery | Medical Devices | Pharmaceutical

Brands

Advancia; Novelia; Rexam Healthcare; Safe n Sound; Safelia; Sof Bag;

Related Companies

  • Gerresheimer
  • Nanoform
  • Adare Pharma Solutions
  • Vetter Pharma International
  • Hermes Pharma GmbH
  • Rentschler Biopharma SE
  • Qualicaps
  • Quotient Sciences

Related Content

Nemera's manufacturing facility inaugurated in Poland
Nemera's manufacturing facility inaugurated in Poland
Nemera to build drug delivery device facility in Poland
Nemera to build drug delivery device facility in Poland
Nemera updates branding and website
Nemera updates branding and website
BIOMM to commercialise Nemera's reusable insulin pen
BIOMM to commercialise Nemera's reusable insulin pen
Nemera to acquire Copernicus
Nemera to acquire Copernicus
Safe’n’Sound Hulio pre-filled syringe launches in Europe
Safe’n’Sound Hulio pre-filled syringe launches in Europe
Nemera's Advancia Snap-on nasal spray pump launches in South Korea
Nemera's Advancia Snap-on nasal spray pump launches in South Korea
Nemera: RetroNose enhances therapeutic efficacy of nasal treatments
Nemera: RetroNose enhances therapeutic efficacy of nasal treatments
Nemera organises an expert review on the present and future of inhalation products
Nemera organises an expert review on the present and future of inhalation products
CPhI Worldwide announces winners of fifteenth Pharma Awards
CPhI Worldwide announces winners of fifteenth Pharma Awards
Nemera's e-Novelia ophthalmic add-on wins award at CPhI Worldwide 2018
Nemera's e-Novelia ophthalmic add-on wins award at CPhI Worldwide 2018
Pharmapack Europe award winners 2018
Pharmapack Europe award winners 2018
Nemera receives drug manufacturing authorisation for Neuenburg plant
Nemera receives drug manufacturing authorisation for Neuenburg plant
Nemera UFRT partnership to develop new nasal drug delivery treatments
Nemera UFRT partnership to develop new nasal drug delivery treatments
Nemera to work on nanotechnologies for cardiovascular diseases
Nemera to work on nanotechnologies for cardiovascular diseases
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company